Enanta Pharmaceuticals, Inc. announced that its stockholders approved an amendment to the 2019 Equity Incentive Plan, increasing the number of shares reserved for issuance by 1,600,000 shares. This decision was made during the Annual Meeting held on March 11, 2026.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.